Australia Oncology Market Analysis and Forecast, 2019-2028

Market Introduction and Overview

The Australia oncology market is expected to grow significantly in the coming years, due to increasing incidences of cancer, technological advancements in cancer treatment, and growing awareness about the disease. The market encompasses a wide range of cancer treatment products and services, including drugs, medical devices, and diagnostic tools.

The Australia oncology market was valued at approximately US$ 230 million in 2022 and is expected to grow at a significant CAGR of 9% over the forecast period. The increasing prevalence of cancer, coupled with the growing demand for advanced treatment options, is driving the growth of the market.

Market Dynamics

The Australia oncology market is expected to grow significantly over the forecast period, driven by the increasing incidence of cancer and the growing demand for advanced treatment options. The market presents significant growth opportunities for players operating in the market, and the competitive landscape is expected to remain intense in the coming years.

Market Segmentation

The Australia oncology market is segmented based on treatment type, end-user, and geography. By treatment type, the market is segmented into chemotherapy, radiation therapy, immunotherapy, hormone therapy, and others. By end-user, the market is segmented into hospitals, clinics, and others. Geographically, the market is segmented into North Australia, South Australia, and Eastern Australia.

Competitive Landscape

The Australia oncology market is highly competitive, with a large number of domestic and international players operating in the market. Some of the key players in the market include Novartis, Roche, Pfizer, AstraZeneca, and Sanofi, among others. These players are adopting various strategies, such as partnerships, collaborations, and mergers and acquisitions, to expand their market share and strengthen their position in the market.

Opportunities and Challenges

The increasing demand for cancer treatment and the growing prevalence of cancer is providing significant growth opportunities for the Australia oncology market. However, the high cost of cancer treatment and the lack of reimbursement for certain cancer treatments may pose a challenge to the growth of the market.

Regional Breakdown in the Market Report

• By Region
  • Australia
    • Western Australia
    • Southern Australia
    • Eastern Australia
    • Northern and Central Australia

Research Methodology

RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.

RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:

• Defining the problem by understanding the type of market and data required by the client.
• Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
• Formulating a hypothesis to create market numbers, forecasts, influencing factors, and their relevance.
• Evaluating and analyzing the data by referring to data sources utilized and leveraged.
• Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.

Primary Intelligence

• RationalStat utilizes surveys, questionnaires, focus groups, and one-to-one interviews with CXOs, industry partners, trade bodies, association members, ex-employees, and industry professionals to collect insights and quantitative/qualitative data specific to client needs. RationalStat quickly gets to the ‘why’ behind the ‘what’ demonstrated by secondary data.
• RationalStat takes a unique approach to arrive at market conclusions and actionable insights for clients.
• We have the technology and strong in-house resource pool with extensive experience in the global and regional markets, across a wide variety of categories and stakeholders.
• Strong language proficiency and capability with coverage across more than 70 language areas.

Secondary Sources

• Annual reports, company filings, investor presentations, product catalogs, and company documents
• Industry and market-related documents available in the public domain
• Paid databases including Bloomberg, Factiva, S&P Capital IQ, FactSet, Refinitiv Eikon, ICIS, EUWID, and Thomson Reuters, among others
• Whitepapers, research papers, and industry blogs

Why Buy this Report?

The report is intended for service providers, manufacturers, industry stakeholders, government organizations, marketing departments, R&D professionals, insurance organizations, regulatory agencies, and market research firms, among others. The report provides an in-depth analysis of market size, consumption patterns, ongoing market trends and challenges, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights to clients to find the right answers to their business questions.